Clinical Trial Update: Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Tri-Luma cream with intense pulsed light (IPL) vs mild inactive control with IPL in melasma; terminated with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%)

Snippet

Sponsor: Galderma R&D | Conditions: Melasma | Phase 4 | Status: TERMINATED | Results posted: 2010-01-11